Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nanobiotix
NBTXCurrent price
2.87 USD
-0.14 USD (-4.65%)
Last closed
2.90 USD
Company
www.nanobiotix.com
ISIN
US63009J1079
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
165 442 400 USD
Yield for 12 month
-63.39 %
1Y
3Y
5Y
10Y
15Y
NBTX
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.40 USDP/E ratio
–Dividend Yield
–Current Year
+31 575 586 USD
Last Year
+5 017 133 USD
Current Quarter
+4 878 994 USD
Last Quarter
+4 878 994 USD
Current Year
+31 575 586 USD
Last Year
+3 982 402 USD
Current Quarter
+4 878 994 USD
Last Quarter
+4 878 994 USD
Key Figures NBTX
1 year
3 years
5 years
10 years
EBITDA
-22 295 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-22.02 %
PEG Ratio
–
Return On Equity TTM
-198.69 %
Wall Street Target Price
10.40 USD
Revenue TTM
42 204 000 USD
Book Value
-0.46 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
182.10 %
Dividend Yield
–
Gross Profit TTM
4 776 000 USD
Earnings per share
-0.78 USD
Diluted Eps TTM
-0.78 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-79.31 %
Dividend Analytics NBTX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History NBTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NBTX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
48.31
Enterprise Value Revenue
3.75
Price Sales TTM
3.92
Enterprise Value EBITDA
-2.45
Price Book MRQ
65.02
Financials NBTX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NBTX
For 52 weeks
2.76 USD
8.96 USD
50 Day MA
4.12 USD
Shares Short Prior Month
30 154
200 Day MA
5.32 USD
Short Ratio
3.92
Shares Short
30 890
Short Percent
0.080 %
BeatStart